# Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC

> **NCT03700333** · PHASE3 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 120 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** S-1 therapy
- **DRUG:** Pemetrexed therapy

## Key facts

- **NCT ID:** NCT03700333
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-20
- **Primary completion:** 2019-10-20
- **Final completion:** 2019-10-20
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03700333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03700333, "Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03700333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*